A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation (NCT04954118) | Clinical Trial Compass
CompletedNot Applicable
A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation
Turkey (Türkiye)40 participantsStarted 2020-03-20
Plain-language summary
During the COVID-19 pandemic, health employees are at high risk of infection. This study aimed to determine experiences with an aerosol box (AB), used with the aim of preventing contamination by droplets during internal jugular vein cannulation which requires close contact with COVID-19 patients, and the necessity to use this device.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients diagnosed with COVID-19 and inserted central venous catheter while being treated in the ward
Exclusion Criteria:
* Patients under the age of 18 years
* Patients who can not lie in the supine position due to severe respiratory distress,
* Patients with thrombus in the right İJV in evaluation with US
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Questionnaire on the Use of Aerosol Boxes
Timeframe: 7 months from the index case of the pandemic in Turkey
2
Catheter-related infection after central venouse catheterization in COVID-19
Timeframe: 7 months from the index case of the pandemic in Turkey
Trial details
NCT IDNCT04954118
SponsorBakirkoy Dr. Sadi Konuk Research and Training Hospital